Seegene saw the highest growth of 1.36% in patent filings in May and 1.99% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 1.32% and grants by 1.99%. GlobalData’s DataBook provides a comprehensive analysis of Seegene‘s patent filings and grants. Buy the databook here.
Seegene has been focused on protecting inventions in South Korea(KR) with 19 publications in Q2 2024
The South Korea(KR) Patent Office dominates the patent filings with nearly 42% of filings. The South Korea(KR), World Intellectual Property Organization(WIPO), United States(US), and European Patent Office(EPO) patent Office are among the top ten patent offices where Seegene is filings its patents. Among the top granted patent authorities, Seegene has 33% of its grants in United States(US) and 33% in China(CN).
Massachusetts Institute of Technology and Broad Foundation could be the strongest competitors for Seegene
Patents related to industrial automation and machine learning lead Seegene's portfolio
Seegene has the highest number of patents in industrial automation followed by, machine learning and healthtech. For industrial automation, nearly 21% of patents were filed and 100% of patents were granted in Q2 2024.
Laboratory equipment related patents lead Seegene portfolio followed by digital signal processors(dsp), and healthcare it
Seegene has highest number of patents in laboratory equipment followed by digital signal processors(dsp), healthcare it, other remote patient monitoring, and image management.
For comprehensive analysis of Seegene's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.